These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The therapeutic journey of benzimidazoles: a review. Bansal Y; Silakari O Bioorg Med Chem; 2012 Nov; 20(21):6208-36. PubMed ID: 23031649 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization and biological evaluation of some novel 2,4-thiazolidinediones as potential cytotoxic, antimicrobial and antihyperglycemic agents. Avupati VR; Yejella RP; Akula A; Guntuku GS; Doddi BR; Vutla VR; Anagani SR; Adimulam LS; Vyricharla AK Bioorg Med Chem Lett; 2012 Oct; 22(20):6442-50. PubMed ID: 22981328 [TBL] [Abstract][Full Text] [Related]
4. Thiazolidine-2,4-dione derivatives: programmed chemical weapons for key protein targets of various pathological conditions. Chadha N; Bahia MS; Kaur M; Silakari O Bioorg Med Chem; 2015 Jul; 23(13):2953-74. PubMed ID: 25890697 [TBL] [Abstract][Full Text] [Related]
5. Discovery of thiazolidine-2,4-dione/biphenylcarbonitrile hybrid as dual PPAR α/γ modulator with antidiabetic effect: in vitro, in silico and in vivo approaches. Hidalgo-Figueroa S; Ramírez-Espinosa JJ; Estrada-Soto S; Almanza-Pérez JC; Román-Ramos R; Alarcón-Aguilar FJ; Hernández-Rosado JV; Moreno-Díaz H; Díaz-Coutiño D; Navarrete-Vázquez G Chem Biol Drug Des; 2013 Apr; 81(4):474-83. PubMed ID: 23289972 [TBL] [Abstract][Full Text] [Related]
6. Synthetic Strategies of Thiazolidine-2,4-dione Derivatives for the Development of New Anti-diabetic Agents: Compressive Review. Ray PK; Shabana K; Salahuddin ; Kumar R Curr Top Med Chem; 2024; 24(10):885-928. PubMed ID: 38500288 [TBL] [Abstract][Full Text] [Related]
7. Rational design and synthesis of some PPAR-γ agonists: Substituted benzylideneamino-benzylidene-thiazolidine-2,4-diones. Chhajed SS; Chaskar S; Kshirsagar SK; Haldar GM; Kar Mahapatra D Comput Biol Chem; 2017 Apr; 67():260-265. PubMed ID: 28193552 [TBL] [Abstract][Full Text] [Related]
8. Chemical Synthesis, Mechanism of Action and Anticancer Potential of Medicinally Important Thiazolidin-2,4-dione Derivatives: A Review. Kumar H; Deep A; Marwaha RK Mini Rev Med Chem; 2019; 19(18):1474-1516. PubMed ID: 31092179 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-inflammatory activity of new arylidene-thiazolidine-2,4-diones as PPARgamma ligands. Barros CD; Amato AA; de Oliveira TB; Iannini KB; Silva AL; Silva TG; Leite ES; Hernandes MZ; Alves de Lima Mdo C; Galdino SL; Neves Fde A; Pitta Ida R Bioorg Med Chem; 2010 Jun; 18(11):3805-11. PubMed ID: 20471839 [TBL] [Abstract][Full Text] [Related]
10. A comprehensive review on the antidiabetic attributes of thiazolidine-4-ones: Synthetic strategies and structure-activity relationships. Pradhan T; Gupta O; Kumar V; Sristi ; Chawla G Arch Pharm (Weinheim); 2023 Feb; 356(2):e2200452. PubMed ID: 36378997 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, hypoglycaemic, hypolipidemic and PPARγ agonist activities of 5-(2-Alkyl/aryl-6-Arylimidazo[2,1-b][1,3,4]thiadiazol-5-yl)methylene-1,3-thiazolidinediones. Khazi MI; Belavagi NS; Kim KR; Gong YD; Khazi IA Chem Biol Drug Des; 2013 Aug; 82(2):147-55. PubMed ID: 23581650 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of thiazolidine-2,4-dione-pyrazole conjugates as antidiabetic, anti-inflammatory and antioxidant agents. Bansal G; Singh S; Monga V; Thanikachalam PV; Chawla P Bioorg Chem; 2019 Nov; 92():103271. PubMed ID: 31536952 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation and in silico studies of 5-(3-methoxybenzylidene)thiazolidine-2,4-dione analogues as PTP1B inhibitors. Mahapatra MK; Kumar R; Kumar M Bioorg Chem; 2017 Apr; 71():1-9. PubMed ID: 28126289 [TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as novel tyrosinase inhibitors. Ha YM; Park YJ; Kim JA; Park D; Park JY; Lee HJ; Lee JY; Moon HR; Chung HY Eur J Med Chem; 2012 Mar; 49():245-52. PubMed ID: 22301213 [TBL] [Abstract][Full Text] [Related]
15. An Insight into the Synthesis and SAR of 2,4-Thiazolidinediones (2,4-TZD) as Multifunctional Scaffold: A Review. Sethi NS; Prasad DN; Singh RK Mini Rev Med Chem; 2020; 20(4):308-330. PubMed ID: 31660809 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and molecular docking studies of thiazolidinediones as PPAR-γ agonists and thymidylate synthase inhibitors. Nazreen S Arch Pharm (Weinheim); 2021 Sep; 354(9):e2100021. PubMed ID: 33988883 [TBL] [Abstract][Full Text] [Related]
17. Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones. Weng JR; Chen CY; Pinzone JJ; Ringel MD; Chen CS Endocr Relat Cancer; 2006 Jun; 13(2):401-13. PubMed ID: 16728570 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic journey of 2,4-thiazolidinediones as a versatile scaffold: An insight into structure activity relationship. Naim MJ; Alam MJ; Ahmad S; Nawaz F; Shrivastava N; Sahu M; Alam O Eur J Med Chem; 2017 Mar; 129():218-250. PubMed ID: 28231521 [TBL] [Abstract][Full Text] [Related]
19. Quantitative structure-activity relationship analysis of thiazolidineones: potent antidiabetic compounds. Vishvakarma VK; Singh P; Dubey M; Kumari K; Chandra R; Pandey ND Drug Metabol Drug Interact; 2013; 28(1):31-47. PubMed ID: 23417104 [TBL] [Abstract][Full Text] [Related]
20. Effects of Thiazolidinediones on metabolism and cancer: Relative influence of PPARγ and IGF-1 signaling. Mughal A; Kumar D; Vikram A Eur J Pharmacol; 2015 Dec; 768():217-25. PubMed ID: 26542126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]